Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Idea to Innovation

University of Waterloo

$15,000.00

Real-time compliance monitoring system for digital therapies and diagnostics

EF 2021-22

Résumé
The Real Time Adherence Monitoring System for Digital Therapies and Diagnostics provides a novel approach for monitoring a patient's compliance to digital therapies (e.g. treatment of the common vision disorder amblyopia) that takes into account many parameters such as eye gaze, eye blinking, head pose, facial expression, relative eye stability and yawning. It is able to detect whether a patient is wearing the 3D glasses required for treatment and/or ophthalmic prescription during therapy. It can detect whether the patient is performing the therapy or someone else (e.g. a sibling). It also detects seven emotions in real-time, namely: "Happy", "Sad", "Disgust", "Neutral", "Anger", "Surprise" and "Scared". Some advantages of this innovation include: (1) ability to track multiple parameters in real-time. (2) produce feedback signals to regain patient's attention to treatment or alert their parent/caregiver/clinician upon detecting that the patient is upset or unengaged. (3) monitor patient adherence and provide detailed adherence analytics. This innovation has applications in the patient and driver monitoring industries as well as the treatment of vision (e.g. amblyopia) and psychiatric disorders (e.g. ADHD). Digital patient monitoring devices are becoming increasing popular for the treatment of a wide range of disorders, particularly within the context of COVID-19. While technological advancements, prevalence of autonomous vehicles and rise in car accidents have made driver monitoring systems highly valuable for the automotive industry. As part of this Market Assessment grant, the selected consultant (Adventus) will perform a thorough market analysis to identify the most suitable market opportunities along with technical, marketing and financial challenges associated with the application of the technology in a particular market segment. A favorable market assessment result will 1) formulate the commercialization strategy and help attract potential licensees 2) form the basis for submitting a follow-on NSERC I2I Phase 1 project proposal.
Programme
Idea to Innovation
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
566670-2021
Name nom
Thompson, Benjamin
Department département
Optometry and Vision Science, School of
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2021
Award amount
15000
Program id
I2IPJ
Program name en
Idea to Innovation
Program name fr
De l'idée à l'innovation
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
9000
Research subject group en
Medical sciences
Research subject group fr
Sciences médicales
Research subject en
Medical sciences
Research subject fr
Sciences médicales
Installment
inst:1
Partie
1
Nb partie
1
Application title
Real-time compliance monitoring system for digital therapies and diagnostics
Keyword
NSERC
Application summary
The Real Time Adherence Monitoring System for Digital Therapies and Diagnostics provides a novel approach for monitoring a patient's compliance to digital therapies (e.g. treatment of the common vision disorder amblyopia) that takes into account many parameters such as eye gaze, eye blinking, head pose, facial expression, relative eye stability and yawning. It is able to detect whether a patient is wearing the 3D glasses required for treatment and/or ophthalmic prescription during therapy. It can detect whether the patient is performing the therapy or someone else (e.g. a sibling). It also detects seven emotions in real-time, namely: "Happy", "Sad", "Disgust", "Neutral", "Anger", "Surprise" and "Scared". Some advantages of this innovation include: (1) ability to track multiple parameters in real-time. (2) produce feedback signals to regain patient's attention to treatment or alert their parent/caregiver/clinician upon detecting that the patient is upset or unengaged. (3) monitor patient adherence and provide detailed adherence analytics. This innovation has applications in the patient and driver monitoring industries as well as the treatment of vision (e.g. amblyopia) and psychiatric disorders (e.g. ADHD). Digital patient monitoring devices are becoming increasing popular for the treatment of a wide range of disorders, particularly within the context of COVID-19. While technological advancements, prevalence of autonomous vehicles and rise in car accidents have made driver monitoring systems highly valuable for the automotive industry. As part of this Market Assessment grant, the selected consultant (Adventus) will perform a thorough market analysis to identify the most suitable market opportunities along with technical, marketing and financial challenges associated with the application of the technology in a particular market segment. A favorable market assessment result will 1) formulate the commercialization strategy and help attract potential licensees 2) form the basis for submitting a follow-on NSERC I2I Phase 1 project proposal.